BBI Solutions OEM Limited (BBI) has announced the successful closing of the acquisition of IBEX Technologies Inc. (IBEX), a leading developer and manufacturer of high-precision enzymes and diagnostic solutions located in Montréal, Québec.
Bespak have announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Group to form a new standalone company.
Zuellig Pharma has announced that it has completed the acquisition of two brands, Cialis (Tadalafil) and Alimta (Pemetrexed), from Eli Lilly and Company for select ASEAN markets.
Stanley Capital Partners announces its portfolio company, Laboratoire X.O, has completed the acquisition of the prescription drug Nimodipine under the brand name Nimotop from Bayer for several markets globally excluding mainland China.
Justin Wilson, a partner and life sciences specialist at European intellectual property firm, Withers & Rogers explores why M&A are pushing to secure a slice of the gene therapy opportunity.
Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive purchase and licence agreement for a portfolio of preclinical gene therapy programmes and enabling technologies from Pfizer Inc.
Jennifer Lopez, director, solutions delivery at Maetrics discusses why heightened due diligence is needed for pharmaceutical manufacturers during mergers and acquisitions.
CDMO, Recipharm, has acquired Sanofi’s manufacturing centre and business located in Holmes Chapel, which will provide the company with a platform to take advantage of the growing respiratory drug market.
According to Catalyst Corporate Finance, UK service-based pharma businesses involved in ‘smart’ areas of the market are experiencing heightened interest from domestic and international acquirers.
Global innovator and provider of cold chain packaging systems for the pharma industry, Softbox, has acquired TP3 Global, which manufactures the ‘SilverSkin’ brand.
